Are you searching for therapy options for your chronic stroke patients? Learn how the FDA-approved Vivistim® can help increase neuroplasticity for improved hand and arm function.
Watch our recorded webinar featuring Dr. Steve Wolf, Emory University, and Dr. Jenna Tosto, Mount Sinai Health System, as they review how Vivistim Therapy boosts neuroplasticity along with the latest clinical data and its application in patient selection. Use of the magnet to engage patients in functional activity outside of the clinic and real-world outcomes in the first series of patients treated at Mount Sinai will also be presented, followed by a Q&A.
Topics of Discussion:
Don't miss this opportunity to discover how Vivistim Therapy™ can help make stroke rehabilitation more effective for your patients.
Please note, this webinar is for healthcare professionals only.
Watch On-Demand Now
Guest Speakers:
The Vivistim® Paired VNS™ System (Vivistim) is intended to be used to stimulate the vagus nerve during rehabilitation therapy to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if you have had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. While not observed in the Vivistim studies, infection leading to explant is a risk associated with any device surgery. For full safety information, please see www.vivistim.com/safety. Individual results may vary.
©2023 MicroTransponder Inc. All rights reserved. Vivistim, Paired VNS, and Vivistim Therapy are trademarks of MicroTransponder Inc.